Clin2
NCT06264414Possibly a fitNot yet recruiting

Study of a new pill for erectile dysfunction in men with enlarged prostate

Prostatic Hyperplasia, BenignErectile Dysfunction

Part of Kidney & urinary, Mental health clinical trials.

This study tests a new medication (DTT106) to help men who have both an enlarged prostate and erectile dysfunction. It aims to see if the drug improves erection problems safely when added to their current prostate treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
262 people
Ages
40 years and older
Study type
Interventional

Who can take part

  • You are a man aged 40 or older.
  • You are sexually active with a partner, averaging at least one attempt at intercourse per week.
  • You are already taking a stable dose of dutasteride and tamsulosin (combined prostate medication).
  • You have a formal diagnosis of erectile dysfunction, with a certain severity score on the IIEF questionnaire.
  • You have not had prostate surgery, radiation, or a penile implant, and you do not have serious heart, kidney, liver, or other uncontrolled health conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07270432Not yet recruiting· Phase 3
Study of a new medicine for enlarged prostate symptoms

This study tests a new medication (called DNN.65.21.005) for men with an enlarged prostate (also called benign prostatic hyperplasia, or BPH) who have bothersome urinary symptoms. The goal is to see if this medication safely relieves symptoms like frequent or difficult urination.

NCT05955001Recruiting· Phase 2/Phase 3
Tadalafil for early urinary symptoms after prostate surgery

This trial studies whether daily tadalafil (5 mg) can improve early urinary trouble and erection function after endoscopic prostate tissue removal. It may help men whose urinary symptoms continued even after prior medicine.

Al Mansurah, Dakahlia Governorate
NCT05558007Recruiting· Phase 2
Topical treatment trial after prostate surgery in men

This Phase 2 study tests how safe and effective a topical medicine (BZ371A) is for men after prostate surgery, with the goal of improving sexual recovery and monitoring side effects. You may be able to join if you meet specific timing, health, and medication criteria after radical prostatectomy.

Belo Horizonte
NCT07146386Not yet recruiting· Phase 3
New pill for enlarged prostate symptoms compared to standard care

This study compares a new once-daily pill to an existing medication for men with an enlarged prostate. It aims to see if the new pill is better at improving urinary symptoms and urine flow.

Hefei, Anhui
NCT07870759Not yet recruiting· Phase 3
Combination therapy for enlarged prostate symptoms

This trial tests whether combining two medicines works better than one alone for easing urinary symptoms caused by an enlarged prostate. If you have bothersome symptoms and a larger prostate, this study may help you find a more effective treatment.

NCT06944145Recruiting· Phase 2
New treatment study for enlarged prostate (BPH)

This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.

Boston, Massachusetts

Hear when a new Erectile Dysfunction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.